NSRX Nasus Pharma, Ltd.: Accounting Value per Share

Public company logo of Nasus Pharma, Ltd. (NSRX)

Nasus Pharma Ltd (NSRX) is scaling B2B supplies of its patented intranasal powders to US clinics. Book value per share data visualizes this process, where the 0.32 level represents the current value. Growth is driven by the commercialization of Taffix and a unique mucosal delivery system, while a narrow focus on respiratory sprays is offset by the availability of products for mass retail.

Nasus Pharma, Ltd. (NSRX) Equity per Share: for the period 08/14/2025 - 10/28/2026

Summary analytical data breakdowns for Nasus Pharma Ltd. (NSRX)

- price and consensus price forecast:
Price Chart Nasus Pharma, Ltd.|NSRX - Fair Value Consensus
- market capitalization data:
Market Valuation Nasus Pharma Ltd|NSRX - Business Value
- book capitalization data:
Net Assets per Single Share Nasus Pharma|NSRX - Accounting Capitalization|Market Capitalization to Book Value Ratio nasuspharma.com|NSRX - Company Total Assets
- debt and liquidity data:
Debt to Equity Nasus Pharma Ltd|NSRX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Nasus Pharma, Ltd.|NSRX - Company Total Debt|Debt to Book Capitalization Ratio Nasus Pharma Ltd|NSRX - Long-Term Debt|Company Current Liabilities Nasus Pharma
Fundamental company valuation:nasuspharma.com, NSRX
Signature product of Nasus Pharma Ltd.

The development of Nasus Pharma Ltd (NSRX) in the innovative intranasal systems segment requires significant capital expenditures, which is reflected in the equity structure. This metric is calculated as the difference between all company assets and liabilities divided by the number of shares, demonstrating the actual value of the owner's stake. An analysis of the actual book value per share allows for an assessment of the business's internal resilience to market volatility and determines a fair support threshold for investments.

Competitor analysis

Net Assets per Single Share Indivior Group (INDV)|Collegium Corp (COLL) - Accounting Value of a Share|Accounting Value per Share Cronos Group Inc.|CGC (canopygrowth.com) - Equity per Share|Net Assets per Single Share High Tide (HITI)|Equity per Share Aurora|Book Value per Share ACHV|Book Value per Share SKYE (Skye Bioscience Inc.)|Net Assets per Single Share Anebulo Pharmaceuticals|Accounting Value of a Share InterCure Ltd INCR|NTRB: Book Value per Share|IGC: Accounting Value per Share|Net Assets per Single Share MIRA|Net Asset Value per Share Flora Growth Inc|IMCC - Accounting Value per Share|Accounting Value of a Share Adial|ARTL - Book Value per Share|Share Book Value ensysce.com (ENSC)|Book Value per Share TTNP (Titan Pharmaceuticals, Inc.)|Greenlane Corp - Book Value per Share|Net Assets per Single Share InMed Pharmaceuticals (INM)|AKAN: Accounting Value of a Share|ENVB (Enveric Biosciences, Inc.) - Net Assets per Single Share|BGXX (Bright Green Corporation) - Accounting Value per Share|Net Assets per Single Share Hempacco Co., Inc. (HPCO)